A follow-up study on the cochlear, vestibular and renal function in children treated with gentamicin in the newborn period.
D001238:Asphyxia Neonatorum / Q000188:drug therapy; D001424:Bacterial Infections / Q000188:drug therapy; D001806:Blood Urea Nitrogen; D002675:Child, Preschool; D003051:Cochlea / Q000502:physiology*; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D005839:Gentamicins / Q000008:administration & dosage / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy*; D007234:Infant, Premature; D007668:Kidney / Q000502:physiology*; D007677:Kidney Function Tests; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D013997:Time Factors; D014724:Vestibular Function Tests; D014725:Vestibular Nerve / Q000502:physiology*
D005839:Gentamicins